Literature DB >> 27815398

Optic pathway glioma volume predicts retinal axon degeneration in neurofibromatosis type 1.

Robert A Avery1, Awais Mansoor2, Rabia Idrees2, Carmelina Trimboli-Heidler2, Hiroshi Ishikawa2, Roger J Packer2, Marius George Linguraru2.   

Abstract

OBJECTIVE: To determine whether tumor size is associated with retinal nerve fiber layer (RNFL) thickness, a measure of axonal degeneration and an established biomarker of visual impairment in children with optic pathway gliomas (OPGs) secondary to neurofibromatosis type 1 (NF1).
METHODS: Children with NF1-OPGs involving the optic nerve (extension into the chiasm and tracts permitted) who underwent both volumetric MRI analysis and optical coherence tomography (OCT) within 2 weeks of each other were included. Volumetric measurement of the entire anterior visual pathway (AVP; optic nerve, chiasm, and tract) was performed using high-resolution T1-weighted MRI. OCT measured the average RNFL thickness around the optic nerve. Linear regression models evaluated the relationship between RNFL thickness and AVP dimensions and volume.
RESULTS: Thirty-eight participants contributed 55 study eyes. The mean age was 5.78 years. Twenty-two participants (58%) were female. RNFL thickness had a significant negative relationship to total AVP volume and total brain volume (p < 0.05, all comparisons). For every 1 mL increase in AVP volume, RNFL thickness declined by approximately 5 microns. A greater AVP volume of OPGs involving the optic nerve and chiasm, but not the tracts, was independently associated with a lower RNFL thickness (p < 0.05). All participants with an optic chiasm volume >1.3 mL demonstrated axonal damage (i.e., RNFL thickness <80 microns).
CONCLUSIONS: Greater OPG and AVP volume predicts axonal degeneration, a biomarker of vision loss, in children with NF1-OPGs. MRI volumetric measures may help stratify the risk of visual loss from NF1-OPGs.
© 2016 American Academy of Neurology.

Entities:  

Mesh:

Year:  2016        PMID: 27815398      PMCID: PMC5177678          DOI: 10.1212/WNL.0000000000003402

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  28 in total

1.  Automatic segmentation, internal classification, and follow-up of optic pathway gliomas in MRI.

Authors:  L Weizman; L Ben Sira; L Joskowicz; S Constantini; R Precel; B Shofty; D Ben Bashat
Journal:  Med Image Anal       Date:  2011-07-21       Impact factor: 8.545

2.  Reproducibility of circumpapillary retinal nerve fiber layer measurements using handheld optical coherence tomography in sedated children.

Authors:  Robert A Avery; Avital Cnaan; Joel S Schuman; Chieh-Li Chen; Natalie C Glaug; Roger J Packer; Graham E Quinn; Hiroshi Ishikawa
Journal:  Am J Ophthalmol       Date:  2014-06-28       Impact factor: 5.258

3.  Longitudinal data analysis for discrete and continuous outcomes.

Authors:  S L Zeger; K Y Liang
Journal:  Biometrics       Date:  1986-03       Impact factor: 2.571

4.  Visual loss in children with neurofibromatosis type 1 and optic pathway gliomas: relation to tumor location by magnetic resonance imaging.

Authors:  L J Balcer; G T Liu; G Heller; L Bilaniuk; N J Volpe; S L Galetta; P T Molloy; P C Phillips; A J Janss; S Vaughn; M G Maguire
Journal:  Am J Ophthalmol       Date:  2001-04       Impact factor: 5.258

Review 5.  Neurofibromatosis 1.

Authors:  Timothy M Lynch; David H Gutmann
Journal:  Neurol Clin       Date:  2002-08       Impact factor: 3.806

6.  Challenges with defining response to antitumor agents in pediatric neuro-oncology: a report from the response assessment in pediatric neuro-oncology (RAPNO) working group.

Authors:  Katherine E Warren; Tina Y Poussaint; Gilbert Vezina; Darren Hargrave; Roger J Packer; Stewart Goldman; Patrick Y Wen; Ian F Pollack; David Zurakowski; Larry E Kun; Michael D Prados; Stefan Rutkowski; Mark W Kieran
Journal:  Pediatr Blood Cancer       Date:  2013-04-26       Impact factor: 3.167

7.  Quantitative MRI criteria for optic pathway enlargement in neurofibromatosis type 1.

Authors:  Robert A Avery; Awais Mansoor; Rabia Idrees; Elijah Biggs; Mohammad Ali Alsharid; Roger J Packer; Marius George Linguraru
Journal:  Neurology       Date:  2016-05-11       Impact factor: 9.910

8.  Feasibility and comparison of visual acuity testing methods in children with neurofibromatosis type 1 and/or optic pathway gliomas.

Authors:  Robert A Avery; Eric Bouffet; Roger J Packer; Arun Reginald
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-02-05       Impact factor: 4.799

Review 9.  Visual acuity in children with low grade gliomas of the visual pathway: implications for patient care and clinical research.

Authors:  Robert A Avery; Rosalie E Ferner; Robert Listernick; Michael J Fisher; David H Gutmann; Grant T Liu
Journal:  J Neurooncol       Date:  2012-07-28       Impact factor: 4.130

10.  The Use of Magnetic Resonance Imaging Screening for Optic Pathway Gliomas in Children with Neurofibromatosis Type 1.

Authors:  Carlos E Prada; Robert B Hufnagel; Trent R Hummel; Anne M Lovell; Robert J Hopkin; Howard M Saal; Elizabeth K Schorry
Journal:  J Pediatr       Date:  2015-07-29       Impact factor: 6.314

View more
  8 in total

Review 1.  Optic Pathway Gliomas in Neurofibromatosis Type 1: An Update: Surveillance, Treatment Indications, and Biomarkers of Vision.

Authors:  Peter M K de Blank; Michael J Fisher; Grant T Liu; David H Gutmann; Robert Listernick; Rosalie E Ferner; Robert A Avery
Journal:  J Neuroophthalmol       Date:  2017-09       Impact factor: 3.042

2.  Volumetric endpoints in diffuse intrinsic pontine glioma: comparison to cross-sectional measures and outcome correlations in the International DIPG/DMG Registry.

Authors:  Margot A Lazow; Martijn T Nievelstein; Adam Lane; Pratiti Bandopadhayhay; Mariko DeWire-Schottmiller; Maryam Fouladi; John W Glod; Robert J Greiner; Lindsey M Hoffman; Trent R Hummel; Lindsay Kilburn; Sarah Leary; Jane E Minturn; Roger Packer; David S Ziegler; Brooklyn Chaney; Katie Black; Peter de Blank; James L Leach
Journal:  Neuro Oncol       Date:  2022-09-01       Impact factor: 13.029

3.  Optic Nerve Measurement on MRI in the Pediatric Population: Normative Values and Correlations.

Authors:  C E Al-Haddad; M G Sebaaly; R N Tutunji; C J Mehanna; S R Saaybi; A M Khamis; R G Hourani
Journal:  AJNR Am J Neuroradiol       Date:  2017-12-07       Impact factor: 3.825

Review 4.  Visual function tests including the role of optical coherence tomography in neurofibromatosis 1.

Authors:  Daphna Mezad-Koursh; Anat Bachar Zipori; Dinah Zur; Lior Degabli; Meital Ben-Dov; Ainat Klein
Journal:  Childs Nerv Syst       Date:  2020-08-04       Impact factor: 1.475

Review 5.  Optical coherence tomography (OCT) in neuro-ophthalmology.

Authors:  Neda Minakaran; Emanuel R de Carvalho; Axel Petzold; Sui H Wong
Journal:  Eye (Lond)       Date:  2020-11-25       Impact factor: 3.775

6.  Sella turcica measurements on lateral cephalograms of patients with neurofibromatosis type 1.

Authors:  Reinhard E Friedrich; Johanna Baumann; Anna Suling; Hannah T Scheuer; Hanna A Scheuer
Journal:  GMS Interdiscip Plast Reconstr Surg DGPW       Date:  2017-03-23

Review 7.  Optic Pathway Glioma in Type 1 Neurofibromatosis: Review of Its Pathogenesis, Diagnostic Assessment, and Treatment Recommendations.

Authors:  Matteo Cassina; Luisa Frizziero; Enrico Opocher; Raffaele Parrozzani; Ugo Sorrentino; Elisabetta Viscardi; Giacomo Miglionico; Edoardo Midena; Maurizio Clementi; Eva Trevisson
Journal:  Cancers (Basel)       Date:  2019-11-14       Impact factor: 6.639

8.  Epidemiology and Survival of Patients With Optic Pathway Gliomas: A Population-Based Analysis.

Authors:  Huanbing Liu; Yong Chen; Xiaowei Qin; Zheng Jin; Yining Jiang; Yubo Wang
Journal:  Front Oncol       Date:  2022-02-11       Impact factor: 6.244

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.